Ophthalmics contributes to Ciba Vision growth:
This article was originally published in Clinica
Novartis, the result of the merger of Swiss companies Ciba and Sandoz, has reported results for 1996. Its ophthalmics and optics division, Ciba Vision, saw sales rise 8% to SwFr 1,206 million ($989 million). Adjusted for exchange rate moves, the rise was a slightly lower 5%, which Novartis attributed equally to ophthalmics and optics.